ArticleIntegrative cancer therapies2014

A phase I dose-finding study of silybin phosphatidylcholine (milk thistle) in patients with advanced hepatocellular carcinoma.

Abby B Siegel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.